Concurrent Diabetic Ketoacidosis and Acute Coronary Syndrome: A Systematic Review of Case Reports
ASIDE Internal Medicine · 2025
DOI: 10.71079/aside.im.071925107 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift ASIDE Internal Medicine, 2025. Verfasst von Ahmed Elbataa Elbataa und 7 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Diabetic ketoacidosis (DKA) and acute coronary syndrome (ACS) represent serious medical emergencies with a complex bidirectional relationship. The clinical presentations and outcomes of these conditions when they co-occur remain incompletely characterized in the literature. We aim to investigate this correlation.
Methods
We systematically searched the PubMed, Scopus, and Web of Science databases, using terms related to acute coronary syndrome (including myocardial infarction, unstable angina, STEMI, and NSTEMI) combined with diabetic ketoacidosis terms, from inception to April 2025, for case reports. The CARE checklist was applied to assess the risk of bias in the included reports.
Results
Twenty-one case reports met inclusion criteria, describing 11 males and 9 females (one unspecified) with a mean age of 51 years. Patients had both type 1 (42.8%) and type 2 (57.1%) diabetes mellitus. Chest pain was the most common presenting symptom (52.3%), but was absent in nearly half of the cases. Six patients (28.5%) on sodium-glucose cotransporter-2 (SGLT2) inhibitors presented with euglycemic DKA. ST-segment elevation was observed in 61.9% of patients, while five patients had normal coronary arteries despite elevated troponin levels. All patients survived after receiving standard DKA management and appropriate cardiac interventions.
Conclusion
This systematic review highlights the importance of maintaining high clinical suspicion for concurrent DKA and ACS, even when typical symptoms such as chest pain or hyperglycemia are absent. We recommend routine cardiac evaluation, including ECG, troponin assessment, and echocardiography, for all DKA patients to ensure early recognition and appropriate management of these potentially life-threatening conditions.
Zitieren
APA
Elbataa, A. E., Gadelmawla, A. F., Akr, L. M., Elnaggar, M. Y., Mahmoud, M., Nassar, O., Abouelmagd, A. A., & Hassan, A. (2025). Concurrent Diabetic Ketoacidosis and Acute Coronary Syndrome: A Systematic Review of Case Reports. ASIDE Internal Medicine. https://doi.org/10.71079/aside.im.071925107
Vancouver
Elbataa AE, Gadelmawla AF, Akr LM, Elnaggar MY, Mahmoud M, Nassar O, et al. Concurrent Diabetic Ketoacidosis and Acute Coronary Syndrome: A Systematic Review of Case Reports. ASIDE Internal Medicine. 2025. doi:10.71079/aside.im.071925107
BibTeX
@article{Elbataa2025,
author = {Elbataa, Ahmed Elbataa and Gadelmawla, Ahmed Farid and Akr, Laila Mohamed and Elnaggar, Mohamed Yasser and Mahmoud, Mohamed and Nassar, Omar and Abouelmagd, Alaa Abdrabou and Hassan, Ahmed},
title = {Concurrent Diabetic Ketoacidosis and Acute Coronary Syndrome: A Systematic Review of Case Reports},
journal = {ASIDE Internal Medicine},
year = {2025},
doi = {10.71079/aside.im.071925107}
}
EUVIMED